Edison Group

Bull, Bear & Beyond by Edison Group

Business EN ↓ 177 episodes

Discover fresh perspectives in the Bull, Bear & Beyond podcast series by Edison Group. Our longer episodes feature candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation and the opportunities shaping their markets. These discussions offer unique insight into how leaders navigate challenges, drive growth and deliver long-term value for stakeholders. Our 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit. To find out more, please visit: https://www.ediso...

Author

Edison Group

Episodes

2. Bull, Bear & Beyond – IRLAB Therapeutics: executive interview 23.09.2024 11:14

"IRLAB Therapeutics (OMX: IRLAB-A) is a Sweden-based biopharma company focused on the development of novel treatments for neurodegenerative diseases, with a particular focus on Parkinson’s disease (PD). The company has a highly active pipeline, with assets spanning all stages of clinical development, from preclinical programmes through to its lead asset, mesdopetam, which is Phase III-ready. *****...

1. Bull, Bear & Beyond – The Biotech Growth Trust in 60 seconds 03.09.2024 1:01

"Edison’s investment companies team recently published a review of The Biotech Growth Trust (BIOG). The trust’s managers Geoff Hsu and Josh Golomb at leading global healthcare specialist OrbiMed are positive on the outlook for biotech stocks. Higher interest rates have pressured the sector’s valuation despite a favourable fundamental industry backdrop, which includes a high level of innovation, el...